Sears Holdings Corporation Announces Filing of Prospectus Supplement for …PR Newswire (press release)Under the terms of the rights offering, the Company is planning to distribute to its stockholders, at no charge, one transferable subscription right for every 85.1872 shares of the Company’s common stock held of record as of 5:00 p.m., New York City … […]
KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDENDStockhouseDALLAS, TEXAS – October 29, 2014 – Kronos Worldwide, Inc. (NYSE: KRO) announced that its board of directors has declared a regular quarterly dividend of fifteen cents ($0.15) per share on its common stock, payable on December 18, 2014 to stockholders … and more …read more
KRONOS WORLDWIDE, INC. ANNOUNCES QUARTERLY DIVIDEND – Stockhouse Read More »
Hydra Industries Acquisition Corp. Announces Closing Of Initial Public OfferingMarketWatchThe Company’s units began trading on the NASDAQ Stock Market under the symbol “HDRAU” on October 24, 2014. Once the securities comprising the units begin separate trading, the common stock, warrants and rights are expected to be listed on the … and more …read more
Axion Power (AXPW) Closes 1.88M Common, Warrants OfferingStreetInsider.com (subscription)Axion Power (NASDAQ: AXPW) announced that is has completed an underwritten public offering consisting of 1,875,000 shares of common stock (“Common Stock“), together with Series A warrants to purchase 1,875,000 shares of its Common Stock (“Series … …read more
Biotech Stocks Hit to New Concerns: Gilead Sciences, Inc.(NASDAQ:GILD), CEL …StreetWise ReportCEL-SCI Corporation (NYSE: CVM) declared the 7,894,737 share of common stock in an underwritten public offering closed and 1,973,684 warrants to buying shares of common stock. For each 4 shares of common stock traded, firm released to investors in … and more …read more
Relmada Therapeutics Adds $15 Million in Capital to Expedite Development of …StockhouseNEW YORK, NY–(Marketwired – October 29, 2014) – Relmada Therapeutics, Inc. (OTCQB: RLMD), a biopharmaceutical firm with four novel pain treatment drugs currently under development in its pipeline, received a healthy injection of more than $15 million … and more …read more
AtheroNova Prices Public Offering of Common Stock and WarrantsVirtual Press Office (press release)The securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5
AtheroNova Prices Public Offering of Common Stock and WarrantsDigitalJournal.comThe securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five … and more
AtheroNova Prices Public Offering of Common Stock and Warrants – DigitalJournal.com Read More »
AtheroNova Prices Public Offering of Common Stock and WarrantsPR Newswire (press release)The securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five
AtheroNova Prices Public Offering of Common Stock and WarrantsMarketWatchThe securities are offered at a price to the public of $0.75 per share of common stock and $0.01 per warrant. The warrants will have an exercise price of $4.00 per share, subject to adjustment, and are exercisable immediately and will expire 5 (five … and more
AtheroNova Prices Public Offering of Common Stock and Warrants – MarketWatch Read More »